Skip to main content
. 2017 Dec 9;9(1):576–590. doi: 10.18632/oncotarget.23076

Figure 5. Determination for the concentration of LXR agonist (× 400, Scale bars = 50 μm).

Figure 5

(A) Change in expression of TH. Maximal expression of TH was obtained at concentrations of 0.5 μM. Thus, 0.5 μM was determined as the concentration of LXR agonist. (B) Group data showing change in expression of TH. Data are expressed as mean ± SD (n = 5). **P < 0.01, compared with concentration of 0.25 μM.